Two investigational antitumor agents work better together against MPNST and neuroblastoma

(Nationwide Children's Hospital) A new study published last week in Oncotarget demonstrates that the combined usage of Aurora A kinase inhibitor (alisertib) and HSV1716 results in significantly increased antitumor efficacy in models of malignant peripheral nerve sheath tumor (MPNST) and neuroblastoma.

Comments
%d bloggers like this: